Blar i forfatter "Kou, Lei"

Viser treff 1-3 av 3

    • Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF 

      Ueland, Thor; Gullestad, Lars; Kou, Lei; Young, James B.; Pfeffer, Marc A.; van Veldhuisen, Dirk J.; Swedberg, Karl; Mcmurray, John J. V.; Desai, Akshay S.; Anand, Inderjit S.; Aukrust, Pål (Journal article; Tidsskriftartikkel; Peer reviewed, 2021-10-05)
      Aims - We aimed to assess the value of GDF-15, a stress-responsive cytokine, in predicting clinical outcomes in patients with heart failure (HF) with reduced ejection fraction (HFrEF) and anemia<p> <p>Methods and results - Serum GDF-15 was assessed in 1582 HFrEF and mild-to-moderate anemia patients who where followed for 28 months in the Reduction of Events by Darbepoetin alfa in Heart Failure ...

    • Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study 

      Ueland, Thor; Gullestad, Lars; Kou, Lei; Aukrust, Pål; Anand, Inder S.; Nordlund, Marianne Sparby; McMurray, John J.; van Veldhuisen, Dirk J.; Warren, David; Bolstad, Nils (Journal article; Tidsskriftartikkel; Peer reviewed, 2018-08-25)
      <p><i>Aims</i>: Neuroendocrine activation is associated with poor outcome in heart failure (HF). The neuropeptide gastrin‐releasing peptide (GRP), derived from the precursor proGRP1‐125 (proGRP), has recently been implicated in inflammation and wound repair. We investigated the predictive value of proGRP on clinical outcomes in HF patients with reduced ejection fraction.</p> <p><i>Methods and ...

    • T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF 

      Abraityte, Aurelija; Aukrust, Pål; Kou, Lei; Anand, Inder S.; Young, James; Mcmurray, John J.V.; van Veldhuisen, Dirk J.; Gullestad, Lars; Ueland, Thor (Journal article; Tidsskriftartikkel, 2018-07-26)
      <i>Background</i>: Activated leukocytes may contribute to the development and progression of heart failure (HF). We investigated the predictive value of circulating levels of stable and readily detectable markers reflecting both monocyte/macrophage and T-cell activity, on clinical outcomes in HF patients with reduced ejection fraction (HFrEF).<p> <p><i>Methods</i>: The association between ...